Candel Therapeutics, Inc. (CADL): Weighted Average Diluted Shares
52.96M
Year ended 2025-12-31
+22.5%
3-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 52.96M | +67.2% | 2026-03-12, From 2025-01-01 |
| 2024-12-31 | 31.68M | +9.5% | 2026-03-12, From 2024-01-01 |
| 2023-12-31 | 28.94M | +0.4% | 2025-03-13, From 2023-01-01 |
| 2022-12-31 | 28.82M | n/c | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | 18.87M | n/a | 2023-03-30, From 2021-01-01 |